[Women, schizophrenia and oestrogen; neurobiological hypotheses and hormonetherapy studies].
BACKGROUND
Gender differences play a role in the origin and course of schizophrenia. It has been hypothesised that the gonadal hormone, oestrogen, may possibly perform a protective function in the development of certain forms of schizophrenia.


OBJECTIVE
To review neurobiological hypotheses concerning the role of oestrogen in the development and course of schizophrenia.


METHODS
The relevant literature was consulted with the help of PubMed, textbooks and bibliographic references; the search terms used were 'oestrogen', 'schizophrenia', 'gender', 'epigenetics', 'psychosis', 'women' and 'brain'. There were no restrictions with regards to the time-period.


RESULTS
Neuro-imaging, animal experiments and hormone-therapy studies showed several effects of oestrogen in the field of epigenetics, morphology of the brain, interaction with neurotransmitters and neuroprotection.


CONCLUSIONS
Oestrogen is an important link in a complex of factors that clearly play a role in the varying development of schizophrenia in men and women. So far, however, there is insufficient evidence to support the existence of a specific mechanism that would explain why oestrogen may perform a protective function in schizophrenia.
Boerma
M A M
MA
m.boerma@ggzingeest.nl
van der Stel
J C
JC
van Amelsvoort
Th
T
Linszen
D H
DH
de Haan
L
L
D044127:Epigenesis, Genetic; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000097:blood / Q000502:physiology*; D005260:Female; D006801:Humans; D012307:Risk Factors; D012559:Schizophrenia / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology* / Q000235:genetics; D012737:Sex Factors
D004967:Estrogens